Navigation Links
Moderate Exercise may not help prevent Heart Disease

A question of whether daily moderate exercise could actually prevent Heart disease. A study found that only vigorous exercise like jogging, hiking, climbing stairs, racket sports and swimming does really help lower the risk of early death from heart disease. Recommendations in the United States and elsewhere say 30 minutes of moderate activity like brisk walking, is sufficient for good heart health.// A World Health Organization report published last month reached the same conclusion. However in a latest study by scientists at Queen's University, Belfast found that activities like walking, bowling, sailing, golfing, dancing and even brisk walking did not lower the risk of early death among 2,000 British men followed for a decade.

Previous research has given conflicting results, dividing experts between a group that believes moderate exercise is enough and a smaller group convinced that vigorous exercise is needed before any heart benefit can occur. A major drawback of the study was that, men were only questioned about their exercise habits one time at the start of the study, so there is no way to know if they have changed their habits over the 10 years the study was conducted. The researchers found that those who did the most exercise were 40 per cent less likely to die than those who did the least.
'"/>




Page: 1

Related medicine news :

1. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
2. Moderate alcohol consumption protects against dementia
3. The Benefits Of A Diet Consisting Of Moderate Amounts Of Fat
4. Moderate drinking can be good for the kidneys
5. Enjoy Moderate Exercise and Keep Your Heart Fit
6. Even Moderate Drinking Is Not Good For The Heart
7. Moderate Drinkers Found to Escape Obesity and Related Problems
8. Moderate Exercise Is Good For The Heart: Study
9. Moderate Drinking Can Help Cut Diabetes Risk In Middle-Aged Women
10. Moderate Drinking Does Not Guard Against Heart Disease
11. Children Benefited By Moderate Maternal Stress?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2017)... and London UK (PRWEB) , ... June 27, 2017 , ... ... to a clinical study is whether they can trust the sponsor to pay them ... is vital that sponsors and CROs establish payment strategies that encourage sites to work ...
(Date:6/27/2017)... ... June 27, 2017 , ... From June 20-22, ... event was held in Syracuse, New York, where EarQ is headquartered. , Together, ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... of Atmosera Managed Azure Services . The trusted, transparent, and secure solution ... the company’s growing customer base. Atmosera’s next generation services include integrated capabilities for ...
(Date:6/27/2017)... CA (PRWEB) , ... June 27, 2017 , ... ... orthodontic treatments . Orthodontics is a dental specialty that focuses on treating alignment ... Benefits include improved aesthetics and function. , North Hollywood dentist , ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)...  Exactly 50 years ago today, the Monterey Pop Festival ... as the San Francisco "Summer of Love."  To celebrate the ... innovations in strategic market research portals that it will begin ... of Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: